# Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity.

> PubMed lists PMID 24090017 in Revista espanola de enfermedades digestivas as Journal Article, Review, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24090017-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-09-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24090017-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-24090017-linaclotide-v1.json
- Content SHA-256: `9aa14d5376dcbf9bf47d9e81d3dc6e127bfd814f95a1d139408c6ad6367542ac`

## Claims and source pins

### Headline

Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

### Summary

PubMed lists PMID 24090017 in Revista espanola de enfermedades digestivas as Journal Article, Review, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

### Paragraph 1

PubMed lists PMID 24090017 in Revista espanola de enfermedades digestivas as Journal Article, Review, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`](#source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617))

## Sources

<a id="source-pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617"></a>
- **Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity. · retained source version 1:2019-09-18:current:022cb5dad6179fb61acdf11c0e13a066135cd953906443075de52f235f884880** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24090017/) (`pubmed-observation-pmid-24090017-2019-09-18-022cb5dad617`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-24090017-linaclotide-v1.json SHA-256: 9aa14d5376dcbf9bf47d9e81d3dc6e127bfd814f95a1d139408c6ad6367542ac.